Hypotenews

Hypotenews

State Regulators Say the DEA Just Split Their Markets in Two

Twelve days from a federal supply chain deadline, the Cannabis Regulators Association warns the framework is fragmenting state programs.

Hypotenews's avatar
Hypotenews
Nov 17, 2026
∙ Paid

From the editor

The week’s most consequential cannabis story did not come from Congress or a courtroom. It came from the people who actually run state cannabis programs, and it was a warning.

Gillian Schauer, who leads the Cannabis Regulators Association, published a detailed argument that the DEA’s medical registration framework has effectively split state markets into two incompatible groups. Businesses that registered or applied in time, and businesses that did not. The two groups face restrictions on transacting with each other, and the deadline for registered operators to establish compliant supply chains is November 29. That is twelve days away.

Everything else this week sits in that shadow. Kentucky’s governor is pushing banking reform as his state’s medical program crosses 30,000 patients. Virginia is already reopening a law it passed this year. Wisconsin sees an opening, Pennsylvania’s Senate leadership is signaling the opposite, and Nebraska cultivators are sitting on harvests they cannot legally test. In Missouri, hemp retailers are liquidating at 70% off.

The pattern underneath all of it is the same. Legalization is no longer the binding constraint on this industry. Implementation is, and implementation is where capital gets destroyed quietly, without anyone passing a law.


1. Kentucky’s governor presses on banking as the medical market scales

Governor Andy Beshear is urging Congress to pass the SAFE Banking Act, and he brought numbers rather than principle.

Kentucky now has 27 operational medical dispensaries spread across all eleven licensing regions, more than 30,000 registered patients, and roughly 500 practitioners certified to issue recommendations. That is a program past the planning stage and into daily commercial operation, which is precisely when banking friction stops being theoretical and starts showing up on income statements.

Beshear joined fifteen other governors on last week’s letter to congressional leadership, and his framing centers on public safety, economic development and financial transparency rather than on the industry’s own convenience. That is a deliberate choice, and a smart one.

The underlying problem is competition, not permission. Banks and credit unions can already serve cannabis businesses, and several hundred do. But federal legal ambiguity and compliance costs have kept the number of willing institutions small, which leaves operators dependent on a handful of specialty providers. Limited supply in any market produces the same result, and here it shows up as pricing power for the few institutions willing to participate.

The cash-handling costs compound it. Security, transport, storage, reconciliation and insurance all carry expenses that a conventional business of equivalent size never incurs, and they land on margins that are already compressed.

What SAFE Banking would not do is change credit analysis. More institutions entering the market means more competition on price and service. It does not mean more borrowers clear underwriting. A thin-margin operator with weak reporting remains a thin-margin operator with weak reporting, and the institutions that enter this space will discover that quickly.

What to watch: whether banking legislation gets floor time in the new Congress, and whether any Republican senators attach to the governors’ momentum.


2. Virginia reopens a law it passed this year

Virginia’s legislative commission on the cannabis retail transition met Monday and recommended changes to a framework the state approved only months ago, which tells you something about how quickly implementation reality diverges from legislative intent.

The headline item is the public consumption penalty, scheduled to rise from $25 to $250 effective July 1, 2027. The commission recommended reconsidering the increase and addressing scenarios where a person could face overlapping penalties for related conduct. That debate has been running since the original bill and it is now reopened.

The provisions that matter commercially are quieter. The commission is weighing clarification of local authority to set minimum distances between cannabis businesses, and limits on how far municipalities can restrict operating hours.

Those details move revenue directly. Two dispensaries with identical demographics and identical build-outs produce different numbers if one operates twelve hours a day and the other eight, and the difference flows through staffing, customer access and ultimately the cap rate a buyer will pay. Distance requirements do the same thing from the other direction, functioning as a density control that protects incumbent locations and shapes what a given parcel is worth.

For anyone underwriting cannabis real estate in Virginia, that is an open variable sitting in the middle of the collateral analysis. Dispensary build-outs carry heavy tenant improvements with limited value to alternative tenants, so the realizable value of the property depends substantially on whether the next operator can use it the same way. A zoning or hours change between origination and default alters that math.

The commission also recommended barring lawmakers and immediate family from holding certain ownership interests. That is a conflict-of-interest provision, and it is the kind of thing that matters more to investor confidence than it does to any individual deal.

What to watch: the 2027 session, and specifically whether local authority over hours and distance gets capped or left open.


3. State regulators warn the federal framework is splitting their markets

This is the story of the week, and it comes from the regulators rather than the industry.

Gillian Schauer, executive director of the Cannabis Regulators Association, argues in published commentary that the DEA’s registration actions have divided state medical markets into two groups that cannot fully transact with each other. One group registered with the DEA or filed timely applications. The other did not, and remains fully licensed under state law.

The DEA has restricted transactions between those groups, and businesses that applied within the window were instructed to establish compliant supply chains by November 29.

Work through what that means operationally. A dispensary that applied may have a primary supplier that did not. A manufacturer may depend on cultivators outside the framework. A testing laboratory may be available to one group and unavailable to the other. Relationships that functioned without incident under state law become non-compliant on a date, and nobody involved did anything wrong.

The obvious fix is unavailable. In a conventional industry, a supplier shortage gets solved by buying from a vendor in the next state. Cannabis cannot do that, because state programs restrict interstate transport regardless of federal registration status. So the fragmentation has no release valve, which is Schauer’s core point and the reason she frames this as a viability question for some operators rather than a compliance inconvenience.

User's avatar

Continue reading this post for free, courtesy of Hypotenews.

Or purchase a paid subscription.
© 2026 Hypotenews by Towelie · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.